We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
84 hedge funds and large institutions have $249M invested in Madrigal Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 84 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
247% more call options, than puts
Call options by funds: $11.1M | Put options by funds: $3.21M
Holders
84
Holders Change
+84
Holders Change %
–
% of All Funds
2.74%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
84
Increased
–
Reduced
–
Closed
–
Calls
$11.1M
Puts
$3.21M
Net Calls
+$7.93M
Net Calls Change
+$7.93M
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $20K | +$29.7K | +114 | New |
|
77
Wells Fargo
San Francisco,
California
| $20K | +$29.7K | +114 | New |
|
78
Citigroup
New York
| $19K | +$28.9K | +111 | New |
|
79
Ameriprise
Minneapolis,
Minnesota
| $15K | +$22.4K | +86 | New |
|
80
Royal Bank of Canada
Toronto,
Ontario, Canada
| $15K | +$22.4K | +86 | New |
|
81
Teacher Retirement System of Texas
Austin,
Texas
| $14K | +$20.9K | +80 | New |
|
82
California Public Employees Retirement System
Sacramento,
California
| $8K | +$12.5K | +48 | New |
|
|
SSG
83
Summit Securities Group
New York
| $6K | +$8.34K | +32 | New |
|
84
BlackRock
New York
| $5K | +$7.56K | +29 | New |
|
MDGL Hedge Fund Activity: Q2 2013 in Review
84 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Madrigal Pharmaceuticals (MDGL) for Q2 2013, worth a combined $249M.
Buyers outnumbered sellers: 84 funds opened new MDGL positions and 0 closed out — a net gain of 84 holders — while 0 added to existing stakes and 0 trimmed.
- 84 institutional investors held Madrigal Pharmaceuticals (MDGL) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $249M of Madrigal Pharmaceuticals stock for Q2 2013.
- 84 funds opened new Madrigal Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +84 holders.
Based on aggregated 13F filings for Q2 2013.